Drug Type Peptide Conjugate Radionuclide, Therapeutic radiopharmaceuticals |
Synonyms DOTA-G-02113-[68Ga], Gallium-68-DOTA-G-02113 |
Target |
Action antagonists, inhibitors |
Mechanism SSTR2 antagonists(Somatostatin receptor 2 antagonists), SSTR5 inhibitors(Somatostatin receptor 5 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United States | - |